The story of the discovery of these molecules 50 years ago shows how the free exchange of ideas can lead to life-changing ...

Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

A collaborative team from the Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of ...

Precision-targeted therapy via antibody drugs has become central to the field of cancer immunotherapy. Monoclonal antibodies (mAbs) have historically played a key role in targeted therapy, but mAbs ...

FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicron COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't ...

The anti-PC antibody is known to protect the body from a condition called atherosclerosis. This happens when the walls of the ...

T cells and/or bispecific antibody (BsAb) has been established and become a promising treatment strategy for ...

A total of 66.9% of patients who received the anti-IL-13 antibody saw a 75% or greater increase in their EASI score, compared to 24.6% of those on placebo, Apogee added in the July 7 release. The ...

A third monoclonal antibody product to protect babies against respiratory syncytial virus was approved by the Food and Drug Administration on Monday, a development public health experts hope may ...

Send comments and news tips to [email protected]. Cite this: Edited by Manasi Talwadekar. Antibody-Drug Conjugate Tackles Glucocorticoid Use in Polymyalgia Rheumatica - Medscape - February 04, 2025.

Bispecific antibodies addressing PD-L1/PD-1 and VEGF have become a hot commodity to drug developers. Summit Therapeutics, Merck, Instil Bio, and Pfizer are among the companies developing ...